Cargando…

Corrigendum to “Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer”

Detalles Bibliográficos
Autores principales:	Yang, Guangda, Jian, Liumeng, Lin, Xiangan, Zhu, Aiyu, Wen, Guohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787784/ https://www.ncbi.nlm.nih.gov/pubmed/33456628 http://dx.doi.org/10.1155/2020/3147825

Ejemplares similares

Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer
por: Yang, Guangda, et al.
Publicado: (2019)

Identification of Key Genes Involved in Diabetic Peripheral Neuropathy Progression and Associated with Pancreatic Cancer
por: Jian, Liumeng, et al.
Publicado: (2020)

Corrigendum to “Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib”
por: Gorini, Stefania, et al.
Publicado: (2019)

Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum]
Publicado: (2022)

Bioinformatics Analysis to Reveal Potential Differentially Expressed Long Non-Coding RNAs and Genes Associated with Tumour Metastasis in Lung Adenocarcinoma [Corrigendum]
Publicado: (2020)

CORRIGENDUM to “Dual-targeting strategy using trastuzumab and lapatinib in a patient with HER2 gene amplification in recurrent metachronous metastatic gallbladder carcinoma”
Publicado: (2020)

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”
por: Wang, TingAn, et al.
Publicado: (2021)

Corrigendum to “Bioinformatics Analysis Reveals the Altered Gene Expression of Patients with Postmenopausal Osteoporosis Using Liuweidihuang Pills Treatment”
por: Gong, Rui, et al.
Publicado: (2019)

Corrigendum to “Molecular Cloning, Bioinformatic Analysis, and Expression of Bombyx mori Lebocin 5 Gene Related to Beauveria bassiana Infection”
por: Lü, Dingding, et al.
Publicado: (2017)

Corrigendum to “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Cao, Yuze, et al.
Publicado: (2017)

Variations in the Wnt/β-Catenin Pathway Key Genes as Predictors of Cervical Cancer Susceptibility [Corrigendum]
Publicado: (2020)

Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer”
por: Hess, Timo, et al.
Publicado: (2023)

Corrigendum to: Biochemical and bioinformatic methods for elucidating the role of RNA-protein interactions in posttranscriptional regulation
por: Kloetgen, Andreas, et al.
Publicado: (2019)

Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum]
Publicado: (2017)

Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer
por: Yu, Chaoran, et al.
Publicado: (2018)

Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges [Corrigendum]
Publicado: (2021)

Corrigendum: MEF2 transcription factors are key regulators of sprouting angiogenesis
por: Sacilotto, Natalia, et al.
Publicado: (2022)

Corrigendum to “Potential of Gene and Cell Therapy for Inner Ear Hair Cells”
por: Lee, Min Young, et al.
Publicado: (2019)

Corrigendum: Comparisons of Gastric Cancer Treatments: East vs. West
por: Bickenbach, Kai, et al.
Publicado: (2012)

Corrigendum to “Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma”
por: Liping, Xu, et al.
Publicado: (2020)

Corrigendum to ‘Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q': [Annals of Oncology 30 (2019) 1821–1830]
por: Jhaveri, K.L., et al.
Publicado: (2021)

PLK1 as a potential prognostic marker of gastric cancer through MEK-ER K pathway on PDTX models [Corrigendum]
Publicado: (2019)

Development and Validation of Multiplex Quantitative PCR Assay for Detection of Helicobacter pylori and Mutations Conferring Resistance to Clarithromycin and Levofloxacin in Gastric Biopsy [Corrigendum]
Publicado: (2023)

KLF7 Promotes Gastric Carcinogenesis Through Regulation of ANTXR1 [Corrigendum]
Publicado: (2021)

[Corrigendum] Crocetin induces apoptosis of BGC‑823 human gastric cancer cells
por: He, Ke, et al.
Publicado: (2023)

Corrigendum to: Psychiatric co-morbidity and substance abuse after gastric bypass surgery
Publicado: (2023)

Corrigendum to “GoldCLIP: Gel-omitted Ligation-dependent CLIP” [Genomics Proteomics Bioinformatics 16 (2) (2018) 136–143]
por: Gu, Jiaqi, et al.
Publicado: (2018)

Daclatasvir: potential role in hepatitis C [Corrigendum]
Publicado: (2014)

Corrigendum to “Potential Extensions of the US FRAX Algorithm”
por: Osteoporosis, Journal of
Publicado: (2018)

Corrigendum
por: Sun, Xiao-Hui, et al.
Publicado: (2015)

MIIP is Downregulated in Gastric Cancer and Its Forced Expression Inhibits Proliferation and Invasion of Gastric Cancer Cells in vitro and in vivo [Corrigendum]
Publicado: (2021)

A Variant of Leptin Gene Decreases the Risk of Gastric Cancer in Chinese Individuals: Evidence from a Case–Control Study [Corrigendum]
Publicado: (2020)

Corrigendum to “Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine” [Genomics Proteomics Bioinformatics 14 (5) (2016) 298–313]
por: Ahmed, Shabbir, et al.
Publicado: (2018)

Corrigendum: Laparoscopic Distal Gastrectomy for Gastric Cancer in Morbidly Obese Patients in South Korea
por: Jung, Ji Yoon, et al.
Publicado: (2014)

Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the Progression of Gastric Cancer [Corrigendum]
Publicado: (2020)

Gastric H(+)/K(+)-ATPase Expression in Normal Laryngeal Tissue and Laryngeal Carcinoma [Corrigendum]
Publicado: (2022)

Folate Decorated Multifunctional Biodegradable Nanoparticles for Gastric Carcinoma Active Targeting Theranostics [Corrigendum]
Publicado: (2022)

Corrigendum to: “Screening Aedes aegypti (Diptera: Culicidae) Populations From Pernambuco, Brazil for Resistance to Temephos, Diflubenzuron, and Cypermethrin and Characterization of Potential Resistance Mechanisms”
Publicado: (2019)

Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456]
por: Tan, Wenliang, et al.
Publicado: (2022)

Treatment Resistant Atopic Dermatitis: Challenges and Solutions [Corrigendum]
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v9i2m6dts9mujnkeo8b36o9m4m